The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype-Reference-Cited by-同舟云学术

The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype

Published:2007 Issue:1 Volume:25 Page:38-43
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Damiani Daniela,Tiribelli Mario,Raspadori Donatella,Michelutti Angela,Gozzetti Alessandro,Calistri Elisabetta,Candoni Anna,Chiarvesio Alexsia,Lenoci Mariapia,Russo Domenico,Fanin Renato

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference26 articles.

1. Long-term survival of patients with acute myeloid leukemia

2. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

3. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

4. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Significance of MRP 1 in Achieving Complete Remission Following Induction Therapy in Acute Myeloid Leukemia;Current Molecular Medicine;2024-07-09

2. Identification of MRP1 and its role in complete remission (CR) after induction therapy in Acute Myeloid Leukemia patients.;2022-09-02

3. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting;Critical Reviews in Oncology/Hematology;2021-04

4. P‐glycoprotein and multidrug resistance‐associated protein‐1 expression in acute myeloid leukemia: Biological and prognosis implications;International Journal of Laboratory Hematology;2020-05-26

5. ABC-transporters and drug efflux in hematologic cancers;Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy;2020